Forget, PatriceAguirre, Jose ABencic, IvankaBorgeat, AlainCama, AllessandroCondron, ClaireEintrei, ChristinaEroles, PilarGupta, AnilHales, Tim GIonescu, DanielaJohnson, MarkKabata, PawelKirac, IvaMa, DaqingMokini, ZhirajrGuerrero Orriach, Jose LuisRetsky, MichaelSandrucci, SergioSiekmann, WiebkeŠtefančić, LjiljaVotta-Vellis, GinaConnolly, CaraBuggy, Donal2025-01-072025-01-072019-04-282072-6694https://hdl.handle.net/10668/26444The question of whether anesthetic, analgesic or other perioperative intervention during cancer resection surgery might influence long-term oncologic outcomes has generated much attention over the past 13 years. A wealth of experimental and observational clinical data have been published, but the results of prospective, randomized clinical trials are awaited. The European Union supports a pan-European network of researchers, clinicians and industry partners engaged in this question (COST Action 15204: Euro-Periscope). In this narrative review, members of the Euro-Periscope network briefly summarize the current state of evidence pertaining to the potential effects of the most commonly deployed anesthetic and analgesic techniques and other non-surgical interventions during cancer resection surgery on tumor recurrence or metastasis.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/analgesiaanesthesiacancerresearch article31035321open access10.3390/cancers11050592PMC6563034https://www.mdpi.com/2072-6694/11/5/592/pdf?version=1556425040https://pmc.ncbi.nlm.nih.gov/articles/PMC6563034/pdf